Investigation of the genetic influence of the OPG, VDR (Fok1), and COLIA1 Sp1 polymorphisms on BMD in the Irish population

Calcified Tissue International

Volumn 71, Issue 1, 2002, Pages 26-35

  Wynne, F ^a   Drummond, F ^a   O'Sullivan, K ^a   Daly, M ^a   Shanahan, F ^a   Molloy, M G ^a   Quane, K A ^a  

^a UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Association study; Low bone mineral density; Osteoprotegerin; Type I collagen alpha 1; Vitamin D receptor

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 1ALPHA 1; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; CALCITRIOL RECEPTOR; CELL RECEPTOR; GLYCOPROTEIN; OSTEOPROTEGERIN; PRIMER DNA; TNFRSF11B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ALLELE; ARTICLE; BINDING SITE; BONE DENSITY; BONE MINERAL; BONFERRONI CORRECTION FACTOR; CONTROLLED STUDY; EXON; FEMALE; FOK1 GENE; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HUMAN; HUMAN CELL; IRELAND; MAJOR CLINICAL STUDY; MUTATIONAL ANALYSIS; OSTEOPOROSIS; OSTEOPROTEGERIN GENE; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; START CODON; VITAMIN D RECEPTOR GENE; BODY HEIGHT; BODY WEIGHT; GENETICS; MASS SCREENING; MENOPAUSE; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

BASE SEQUENCE; BODY HEIGHT; BODY WEIGHT; BONE DENSITY; CODON, INITIATOR; COLLAGEN TYPE I; DNA PRIMERS; FEMALE; GLYCOPROTEINS; HUMANS; IRELAND; MASS SCREENING; MENOPAUSE; MIDDLE AGED; OSTEOPROTEGERIN; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; POSTMENOPAUSE; PREMENOPAUSE; PROMOTER REGIONS (GENETICS); RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; RETROSPECTIVE STUDIES;

EID: 0036653386     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00223-001-2081-z     Document Type: Article

References (56)

1. Conference CD (1993) Diagnosis, prophylaxis and treatment of osteoporosis. A M J Med 94:646-650
2. Kelly PJ, Morrison NA, Sambrook PN, Nguyen TV, Eisman JA (1995) Genetic influences in bone turnover, bone density and fracture. Eur J Endocrinol 133:265-271
3. Gueguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G (1995) Segregation analysis and variance components analysis of bone mineral density in healthy families. J Bone Miner Res 10(12):2017-2022
4. Grant SF, Reid DM, Blake G, Herd R, Fogelman I, Ralston SH (1996) Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet 14(2):203-205
5. Langdahl BL, Ralston SH, Grant SF, Eriksen EF (1998) An Sp1 binding site polymorphism in the COLIA1 gene predicts osteoporotic fractures in both men and women. J Bone Miner Res 13(9):1384-1389
6. Uitterlinden AG, Burger H, Huang Q, et al. (1998) Relation of alleles of the collagen type I alpha 1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 338(15):1016-1021
7. McGuigan FE, Reid DM, Ralston SH (2000) Susceptibility to osteoporotic fracture is determined by allelic variation at the Sp1 site, rather than other polymorphic sites at the COLIA1 locus. Osteoporos Int 11(4):338-343
8. Alvarez L, Oriola J, Jo J, et al. (1999) Collagen type I alpha 1 gene Sp1 polymorphism in premenopausal women with primary osteoporosis: improved detection of Sp1 binding site polymorphism in the collagen type 1 gene. Clin Chem 45(6 Pt 1):904-906
9. Keen RW, Woodford-Richens KL, Grant SF, Ralston SH, Lanchbury JS, Spector TD (1999) Association of polymorphism at the type I collagen (COLIA1) locus with reduced bone mineral density, increased fracture risk, and increased collagen turnover. Arthritis Rheum 42(2):285-290
10. Roux C DM, Abel L, Mercier G, Lucotte G (1998) Association of a polymorphism in the collagen I a1 gene with osteoporosis in French women. Arthritis Rheum 41:187-188
11. Weichetova M, Stepan JJ, Michalska D, Haas T, Pols HA, Uitterlinden AG (2000) COLIA1 polymorphism contributes to bone mineral density to assess prevalent wrist fractures. Bone 26(3):287-290
12. Braga V, Mottes M, Mirandola S, et al. (2000) Association of CTR and COLIA1 alleles with BMD values in peri- and postmenopausal women. Calcif Tissue Int 67(5):361-366
13. Garnero P, Borel O, Grant SFA, Ralston SH, Delmas PD (1998) Collagen Ia1 Sp1 polymorphism, bone mass and bone turnover in healthy French premenopausal women. The OFELY study. J Bone Miner Res 13:813-817
14. Hampson G, Evans C, Petitt RJ, et al. (1998) Bone mineral density, collagen type 1 alpha 1 genotypes and bone turnover in premenopausal women with diabetes mellitus. Diabetologia 41(11):1314-1320
15. Efstathiadou Z, Kranas V, Ioannidis JP, Georgiou I, Tsatsoulis A (2001) The Sp1 COLIA1 gene polymorphism, and not vitamin D receptor or estrogen receptor gene polymorphisms, determines bone mineral density in postmenopausal Greek women. Osteoporos Int 12(4):326-331
16. Liden M, Wilen B, Ljunghall S, Melhus H (1997) Polymorphism at the Sp1 binding site in the collagen type I a1 gene does not predict bone mineral density in postmenopausal women in Sweden. Calcif Tissue Int 63:293-295
17. Hustmyer FG, Liu G, Hustmyer, Johnston CC, Christian J, Peacock M (1999) Polymorphism at an Sp1 binding site of COLIA1 and bone mineral density in premenopausal female twins and elderly fracture patients. Osteoporos Int 9:346-350
18. Heegaard A, Jorgensen HL, Vestergaard AW, Hassager C, Ralston SH (2000) Lack of influence of collagen type Ialpha1 Sp1 binding site polymorphism on the rate of bone loss in a cohort of postmenopausal Danish women followed for 18 years. Calcif Tissue Int 66(6):409-413
19. Aerssens J, Dequeker J, Peeters J, Breemans S, Broos P, Boonen S (2000) Polymorphisms of the VDR, ER and COLIA1 genes and osteoporotic hip fracture in elderly postmenopausal women. Osteoporos Int 11(7):583-591
20. Sowers M, Willing M, Burns T, et al. (1999) Genetic markers, bone mineral density, and serum osteocalcin levels. J Bone Miner Res 14(8):1411-1419
21. De Vernejoul MC, CohenSolal ME, Beaudreuil J (1997) Polymorphism of collagen I and vertebral osteoporosis: no association. J Bone Miner Res 12:S549
22. Efstathiadou Z, Tsatsoulis A, Ioannidis JP (2001) Association of collagen Ialpha 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis. J Bone Miner Res 16(9):1586-1592
23. Mann V, Hobson EE, Li B, et al. (2001) A COLIA1 Sp1 binding site polymorphism predisposes to osteoporotic fracture by affecting bone density and quality. J Clin Invest 107(7):899-907
24. Audi L, Ciarace-Ramirez M, Carrascosa A (1999) Genetic determinants of bone mass. Horm Res 51:105-123
25. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D (1996) The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in postmenopausal Mexican-American women. J Bone Miner Res 11(12):1850-1855
26. Harris SS, Eccleshall TR, Gross C, Dawson-Hughes B, Feldman D (1997) The vitamin D receptor start codon polymorphism (fokI) and bone mineral density in premenopausal American black and white women. J Bone Miner Res 12(7):1043-1048
27. Lucotte G, Mercier G, Burckel A (1999) The vitamin D receptor FokI start codon polymorphism and bone mineral density in osteoporotic postmenopausal French women. Clin Genet 56(3):221-224
28. Gennari L, Becherini L, Mansani R, et al. (1999) fokI polymorphism at translation initiation site of the vitamin D receptor gene predicts bone mineral density and vertebral fractures in postmenopausal Italian women. J Bone Miner Res 14(8):1379-1386
29. Arai H, Miyamoto K, Taketani Y, et al. (1997) A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 12(6):915-921
30. Ames SK, Ellis KJ, Gunn SK, Copeland KC, Abrams SA (1999) Vitamin D receptor gene fok1 polymorphism predicts calcium absorption and bone mineral density in children. J Bone Miner Res 14(5):740-746
31. Ferrari S, Rizzoli R, Manen D, Slosman D, Bonjour JP (1998) Vitamin D receptor gene start codon polymorphisms (fokI) and bone mineral density: interaction with age, dietary calcium, and 3′-end region polymorphisms. J Bone Miner Res 13(6):925-930
32. Eccleshall TR, Garnero P, Gross C, Delmas PD, Feldman D (1998) Lack of correlation between start codon polymorphism of the vitamin D receptor gene and bone mineral density in premenopausal French women: the OFELY study. J Bone Miner Res 13(1):31-35
33. Cheng WC, Tsai KS (1999) The vitamin D receptor start codon polymorphism (fok1) and bone mineral density in premenopausal women in Taiwan. Osteoporos Int 9(6): 545-549
34. Zmuda JM, Cauley JA, Danielson ME, Theobald TM, Ferrell RE (1999) Vitamin D receptor translation initiation codon polymorphism and markers of osteoporotic risk in older African-American women. Osteoporos Int 9(3):214-219
35. Simonet W, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309-319
36. Yasuda H, Shima N, Nakagawa N, Mochizuki S, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Moringa T, Higashio K (1998) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329-1337
37. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS (1998) Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260-1268
38. Moringa T, Nakagawa N, Yasada H, Tsuda E, Higashio K (1998) Cloning and characterisation of the gene encoding human osteoprotegerin/osteoclastogenesis inhibitory factor. Eur J Biochem 254:685-691
39. Wuyts W, Van Wesenbeek L, Morales-Piga A, Ralston S, Hocking L, Vanhoenacker F, Westhovens R, Verbruggen L, Anderson D, Hughes A, Van Hul W (2001) Evaluation of the role of RANK and OPG genes in Paget's disease of bone. Bone 28(1):104-107
40. Old JM (1983) In: D W (ed) Methods in haematology. Churchill-Livingston, Edinburgh, p 74
41. Vaughan P, McCarthy TV (1998) A novel process for mutation detection using uracil DNA-glycosylase. Nucleic Acids Research 26:810-815
42. Vaughan P, McCarthy TV (1999) Glycosylase mediated polymorphism detection (GMPD), a novel process for genetic analysis. Genet Anal (Biomolecular Engineering) 15(5-6):169-175
43. Vaughan P (2000) Use of uracil DNA glycosylase in the detection of known DNA mutations and polymorphisms: glycosylase mediated polymorphism detection (GMPD-check). In: Vaughan P (ed) DNA repair protocols. Humana Press, NJ, USA, pp 169-177
44. Vaughan P (2000) Use of uracil DNA glycosylase in the detection of unknown DNA mutations and polymorphisms: glycosylase mediated polymorphism detection (GMPD-scan). In: Vaughan P (ed) DNA repair protocols. Humana Press, NJ, USA, pp 179-186
45. McGrath A, Vaughan P, McCarthy TV (1998) A DNA glycosylase-based approach for accurate identification of amplified DNA products and its application in the accurate diagnosis of infectious organisms. Anal Biochem 259(2):288-292
46. Manning B, Quane K, Ording H, et al. (1998) Identification of novel mutations in the ryanodine-receptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation. Ant J Hum Genet 62(3):599-609
47. Lynch PJ, Tong J, Lehane M, et al. (1999) A mutation in the transmembrane/luminal domain of the ryanodine receptor is associated with abnormal Ca2 + release channel function and severe central core disease. Proc Natl Acad Sci USA 96(7):4164-4169
48. O'Donnell KA, Tighe O, O'Neill C, et al. (2001) Rapid detection of theR408W and I65T mutations in phenylketonuria by glycosylase-mediated polymorphism detection (GMPD). Hum Mutat 17(5):432
49. Rychlik W RR (1989) A computer program for choosing optimal oligonucleotides for filter hybridisation, sequencing and in vitro amplification of DNA. Nucl Acids Res 17:8543-8551
50. Sham P (1998) Statistics in human genetics. Arnold, London
51. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N (1994) The diagnosis of osteoporosis. J Bone Miner Res 9(8):1137-1141
52. Melton LJ 3rd, Chrischilles EA, Cooper C, Lane AW, Riggs BL (1992) Perspective. How many women have osteoporosis? J Bone Miner Res 7(9):1005-1010
53. Thirunavukkarasu K, Miles RR, Halladay DL, et al. (2001) Stimulation of osteoprotegerin (OPG) gene expression by transforming growth factor-beta (TGF-beta). Mapping of the OPG promoter region that mediates TGF-beta effects. J Biol Chem 276(39):36241-36250
54. Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF (1996) Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med 2(10):1132-1136
55. Brandstrom H, Stiger F, Michaelsson K, Gillberg P, Ljunghall S, Ljunggren O, Kindmark A (1999) Polymorphism in the promoter region of the human gene for osteoprotegerin: correlation with bonc mineral density. J Bone Miner Res 14(suppl 1):S334
56. Duncan E, Wass JA, Brown M (2000) Linkage studies implicate OPGL/TRANCE but not OPG or RANK in the control of bone density. J Bone Miner Res 15:S214